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Abstract 
Squamous cell carcinoma (SCC) is, behind Basal cell carcinoma, the second most 
common cancer of the skin in humans. Very similar skin cancers are also observed in 
veterinary medicine, specifically in cats. SCC has been linked to a variety of causative 
associations, including papillomavirus (PV) infection. Whereas close to 100 human 
PV types have been isolated and completely sequenced, only one single feline PV is 
known. However its association with feline SCC has been discussed controversially. 
The purpose of the present study was to detect PV DNA by PCR in samples 
representing different types of feline SCC and to sequence the amplified DNA. Indeed 
PV DNA was detected in 18% of samples representing invasive SCC and in 23% of 
samples representing in situ SCC, whereas all non-tumoral control samples were 
negative. For the first time PV DNA had been detected in association with feline 
invasive SCC. Moreover, sequencing of the amplification products strongly suggested 
that a number of novel feline PVs had been detected. 
The significance of the present report is based on the evidence that thus far unknown 
papillomaviruses can be found in association with various forms of feline SCC. In the 
future, isolation and further characterization of those viruses will contribute to novel 
insights into the pathogenesis of papilloma-associated diseases in felines. 
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Squamous cell carcinoma is, after basal cell carcino-ma, the second most common cancer of the skin in
humans.1,2 Squamous cell carcinoma involves cancerous
changes to the cells of the middle portion of the epider-
mal skin layer. This cancer may begin in normal skin;
in skin at the site of a burn, injury, or scar; or at a site
of chronic inflammation.1 Most often, it originates from
AK, a precancerous skin growth associated with sun
exposure.3 However, AK is often regarded as a form of
SCC, which is confined to the epidermis; thus, AK is
also referred to as in situ SCC.3-6 A second form of in
situ SCC, precancerous dermatitis (termed Bowen’s dis-
ease), presents as 1 or more flat red scaly patches up to
several centimeters wide, often found in large num-
bers.1,4,6 In situ SCC can persist as such; regress; or
develop into a third, even more malignant form, inva-
sive SCC. Similar skin cancers are also observed in vet-
erinary medicine, specifically in cats.7 Squamous cell
carcinoma has been linked to a variety of causative
associations, which include exposure to UV or ionizing
radiation; arsenic ingestion; toxic exposure to tars and
oils; immunosuppression from drugs such as cortico-
steroids, azathioprine, and cyclosporine; and last but
not least, to PV infection.1,8-10
Papillomaviruses are host-specific epitheliotropic
DNA viruses that infect skin and mucous membranes.
In general, PV infections are benign, result in a latent
infection, or induce microlesions or benign neo-
plasias.11-14 However, a subset of HuPVs and other ani-
mal PVs is clearly implicated in the development of
cancer.10, 14-17 Human PVs that cause mucosal and skin
carcinomas in humans are referred to as high-risk PVs
or epidermodysplasia verruciformis–associated HuPV
types, respectively.14
Close to 100 HuPV types have been described on
the basis of isolation of complete genomes.13
Knowledge on the combination of biological properties
and sequence similarities led to the definition of new
criteria to define genera, species, types, subtypes, and
variants within the Papillomaviridae family.13
In contrast to the numerous HuPVs, only a single
FePV has been identified.18 However, the existence of a
few other FePVs has been suggested on the basis of
findings from several clinical and immunohistochemi-
cal studies.19-22
Until now, little has been known about the pres-
ence of PVs in SCCs of cats. Investigators in 1 study23
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and in situ squamous cell carcinomas from cats
Gilles Nespeca, Med Vet; Paula Grest, DVM; Wayne S. Rosenkrantz, DVM;
Mathias Ackermann, DVM, PhD; Claude Favrot, DrVet, MS
Objective—To detect and partially characterize papil-
lomavirus (PV) DNA in squamous cell carcinoma
(SCC) tumor specimens from cats.
Sample Population—54 formalin-fixed paraffin-
embedded skin biopsy specimens were examined.
Specimens originated from Bowenoid in situ SCC
(BISC; n = 21), invasive SCC (22), and skin affected by
miscellaneous nonneoplastic conditions (11).
Procedures—Samples from each tissue block under-
went DNA extraction after deparaffinization, and PCR
assays were performed. Two sets of primers derived
from PV E1 were used. The first set of primers was
designed for the narrow-range PCR assay and was
able to generate amplification products of feline PV
(FePV), canine oral PV, or closely related PVs. The sec-
ond set of primers was selected for the broad-range
PCR assay because of its ability to amplify DNA from
64 human PVs. Sequence analysis of each amplified
DNA was performed.
Results—1 of the 21 specimens of BISC was positive
for PV DNA on the basis of narrow-range PCR assay
results, whereas all the other specimens (BISC, inva-
sive SCC, and controls) had negative results for PV
DNA. In contrast, 5 of 21 BISC specimens and 4 of 22
invasive SCC specimens were positive for PV DNA on
the basis of broad-range PCR assay results.
Sequence analysis revealed that only 1 specimen was
infected by a virus closely related to classic FePV. In
the 8 other specimens positive for PV DNA, DNA of
unknown PVs was uncovered.
Conclusions and Clinical Relevance—Bowenoid in
situ SCC and invasive SCC of cats may be associated
with PVs of genetic diversity. (Am J Vet Res
2006;67:2036–2041)
ABBREVIATIONS
AK Actinic keratosis 
SCC Squamous cell carcinoma 
PV Papillomavirus
HuPV Human PV
FePV Feline PV
BISC Bowenoid in situ SCC
CaPV Canine PV
BoPV Bovine PV
failed to uncover PV antigen in SCCs of cats, whereas
findings in another study24 revealed the presence of PV
antigens in 44% of tumor specimens of BISC from cats.
Furthermore, PV DNA has been uncovered in tumor
specimens from fibropapillomas, another type of cuta-
neous proliferative disease, of cats.25
Similar to the human disease types, 3 varieties of
SCC have been described for cats, which are AK, BISC,
and invasive SCC.26 Actinic keratosis usually occurs as
a solitary lesion on sun-exposed, lightly haired areas,
such as ear tips, external nares, or eyelids. White cats
are predisposed for the development of such lesions.
On the other hand, BISC is characterized usually by
multiple well-circumscribed, hyperpigmented lesions
that occur frequently on the face, neck, and limbs.27,28
To our knowledge, comparative studies of these 2 early
forms of cancer have not been performed in cats.
The purpose of the study reported here was to
detect PV DNA in specimens representing the various
types of SCC in cats and in specimens from feline skin
with various nontumor conditions. We wanted to test
whether tumor specimens from cats with SCC were
more often infected by PVs than nontumor skin speci-
mens. Two types of PCR assays, narrow and broad
range, were applied to extend the range of targeted PVs
as far as possible.
Materials and Methods
Tissue specimens—Tissues were obtained from the col-
lections of the Prairie Diagnostics Services, Western College
of Veterinary Medicine, University of Saskatchewan,
Saskatoon, SK, Canada; the Institut de Pathologie et de géné-
tique, Loverval, Belgium; Rest associates, London; and, the
Pathology Institute, Vetsuisse Faculty, University of Berne,
Berne, Switzerland. Fifty-four formalin-fixed paraffin-
embedded skin biopsy specimens were examined. Specimens
originated from BISC (n = 21), invasive SCC (22), and mis-
cellaneous skin conditions other than skin cancers (eg, aller-
gic dermatitis; 11) that were used as negative controls.
Specimens from white cats or from locations typical for AK
such as ear tips and eyelids were excluded from this study.
Thirty-micrometer-thick sections were cut from each tissue
block, with a new disposable microtome blade for each
block, before DNA extraction. Two canine warts, which had
histopathologic characteristics of typical PV-induced inclu-
sion bodies, and 1 bovine fibropapilloma served as positive
controls.
DNA extraction—The protocol of Albini et al29 was used
for DNA extraction. Briefly, each section was deparaffinized
twice with 1.2 mL of xylene at room temperature (approx
20oC) for 10 minutes, washed with 100% ethanol, and then
dried at 37oC for 30 minutes. Desiccated samples were sus-
pended in a tissue lysis buffer (50mM Tris-HCl [pH 8.5],
1mM ethilenediaminetetraacetic acid, and 2.8% sodium
dodecylsulfate) and proteinase K (20 mg/mL) and incubated
at 56oC on a rocking platform overnight. After lysis, samples
were transferred to a columna and centrifuged to reduce vis-
cosity. The DNA was precipitated with absolute ethanol and
extracted with a commercial DNA kit.b
Primers—Two sets of primers were used for the PCR
assay. Because the sequences encoding E1 are highly con-
served, the E1 regions of FePV (GenBank accession No.
AF480454) and CaPV (GenBank accession No. NC001619)
were aligned to design a set of consensus primers (ie, PapF,
5′-ATGGCGGGMTARAAAAGGTA-3′ and PapR, 5′-
AACAGCTGYTTTTTARCYTTTTT-3′) for narrow-range PCR
assay, which is able to generate amplification products of
approximately 341 bp of FePV, CaPV, or closely related PVs.
The second set of primers (ie, CP4, CP5, and PPF1
primers), also derived from E1, was selected for broad-range
PCR assay with the objective of amplifying as many PVs as
possible. With this set of primers, up to 64 HuPVs are iden-
tifiable.30 The expected size of the PCR product was approxi-
mately 450 bp.
PCR assay and agarose gel electrophoresis—
Polymerase chain reaction conditions for PapF and PapR
were performed. Volumes of 30 mL were used. Each reaction
contained 1 µL of genomic DNA, 200µM of each deoxynu-
cleoside triphosphate, 0.3µM of each of the sense and anti-
sense primers, and 2.5 units of a DNA polymerase.c After an
initial denaturation step at 95oC for 4 minutes, PCR assay
was performed for 30 cycles at 95oC for 1 minute, 50oC for 1
minute, and 74oC for 1 minute, with a final elongation step
at 74oC for 5 minutes. Deoxyribonucleic acid extracted from
canine warts served as positive control, whereas DNA- and
RNA-free water was used as negative control.
The PCR mix with CP4, CP5, and PPF1 primers was
identical to the mix for narrow-range PCR assay, except that
0.45µM of the CP4 and CP5 primers and 0.3µM of the PPF1
primer were used. The PCR assay consisted of a denaturation
step at 95oC for 10 minutes, followed by 40 cycles at 95oC for
1 minute, 47oC for 1 minute, and 74oC for 1 minute, with a
final elongation step at 75oC for 5 minutes. An extract from 1
bovine fibropapilloma served as an additional positive control.
Polymerase chain reaction products were segregated by
agarose gel electrophoresis, and bands were viewed under UV
light after ethidium bromide staining. Bands on the gel were
excised, and DNA was extracted with a gel extraction kit.d
Amplified DNA was sequenced by use of fluorescent
sequencing and terminator chemistry.e
Sequence analysis—Samples were considered positive
for PV DNA if they met the following requirements: they
had a band of the expected size after gel electrophoresis and
the sequenced DNA had homology with E1 of previously
sequenced PVs. Homologous DNA sequences were searched
for by use of the National Center for Biotechnology
Information GenBank via a BLAST search.f Sequence
alignments and phylogenetic trees were made from
the clustal algorithm obtained by use of a software
program.g
Results
Macro- and microscopic analysis—A careful
macroscopic selection and microscopic confirmation
of affected specimens was a major prerequisite prior
to the virologic analysis. Specimens representing
invasive SCC had been resected from sun-exposed or
white areas of 21 domestic shorthaired cats and 1
Persian cat (12 males and 10 females). Twenty-two
specimens from ear tips (n = 11), nose (3), eyelids
(3), digits (3), and lips (2) met criteria required for
invasive SCC. These criteria included the macroscop-
ic presence of scaly-to-crusty and erosive-to-plaque-
like or ulcerative lesions (Figure 1). The growth
process was always endophytic. Histologically, cords
or islets of infiltrative cells were detected in all speci-
mens. Furthermore, anisocytosis; anisokaryosis;
large, hyperchromatic nuclei; prominent nucleoli;
increased mitotic index; and abnormal mitoses were
encountered in all specimens with variable intensity
and in variable proportion. In addition, keratin pearls
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and intercellular bridges were present in 16 and 12
specimens, respectively.
A second group of 21 tumor specimens met the
criteria for BISC. These specimens were obtained
from the face (n = 16), neck (12), and limbs (3) or
were scattered (2). Thirteen domestic shorthair cats,
3 domestic longhair cats, 2 Siamese, 1 Persian, 1
Himalayan, and 1 Cornish Rex were affected.
Macroscopically, the lesions were squamous crustosus
and grossly circular. Two lesions had a single center,
but 19 were multicentric (Figure 1). Microscopically,
the following criteria were met for BISC: moderate-to-
severe parakeratotic hyperkeratosis, acanthosis with
papillomatous hyperplasia (n = 1) or irregular hyper-
plasias (20), loss of polarity, and scattered dyskeratot-
ic keratinocytes atypia in all layers of the epidermis
and usually also in the infundibulum and reaching
the isthmus. Furthermore, the following types of
atypia were recorded: enlarged nuclei, anisokaryosis,
monster cells (bizarre multinucleated giant cells),
and abnormal mitotic figures. Hyperpigmentation
was found in all but 3 specimens. Fifteen of the 21
specimens had clumped keratohyalin granules, which
were considered as suggestive for PV infection.
However, other signs such as koilocytosis and nuclear
inclusion bodies were not detected.
With the exception of the ulcerated lesions, the
dermis of all samples was considered normal and not
heavily inflamed (Figure 1). Thus, a total of 22 samples
representing invasive SCC and 21 samples representing
BISC were available for virologic analysis by PCR assay
and sequencing.
PCR assays—The narrow-range PCR assay ampli-
fied PV DNA extracted from canine warts but not DNA
extracted from bovine fibropapilloma (Figure 2). In
contrast, the broad-range PCR assay amplified PV DNA
from canine warts and bovine fibropapilloma. It was
concluded that both PCR assays were able to specifi-
cally amplify selected PV DNAs.
The narrow-range PCR assay was applied to sam-
ples from invasive SCC and BISC specimens; 1 BISC
sample (BISC sample No. 15; Appendix; Figure 3) had
positive results for PV DNA, whereas the others had
negative results. Next, the broad-range PCR assay was
applied to the same samples. Interestingly, 5 of 21 BISC
samples (BISC sample Nos. 2, 5, 6, 10, and 15) as well
as 4 of 22 SCC samples (SCC sample Nos. 15, 24, 28,
and 29) had positive results for PV DNA (Figure 2).
One of the samples that had positive results for PV
DNA on the broad-range PCR assay (BISC sample No.
15) also had positive results for PV DNA on the nar-
row-range PCR assay. These results suggested that the
broad-range PCR assay was indeed able to uncover PVs
that were different from the known FePV and CaPVs.
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Figure 1—Macroscopic and microscopic lesions of SCCs in cats.
A—Photograph of invasive SCC in a cat with ulceration of the
eyelid. B—Photomicrograph of a section of the invasive SCC
from panel A at low magnification. Notice invasive proliferation
of atypical keratinocytes with pearl formation (white arrow) and
the cornified layer (red arrow). The basal membrane is not dis-
cernible. The dermis (long arrow) is invaded by cords of atypical
keratinocytes (short black arrow, pointing towards such an inva-
sive site). H&E stain; bar = 200 µm. C—Photomicrograph of a
section of the invasive SCC from panel A at high magnification.
Notice islets of keratinocytes with features of malignancy, such
as anisokaryosis, anisocytosis, multinucleated cells (short
arrow), and abnormal mitosis (long arrow). H&E stain; bar = 50
µm. D—Photograph of BISC in a cat with circular, crusted, ero-
sive, and hyperpigmented plaques (arrow). E—Photomicrograph
of a section of the BISC from panel D at low magnification. The
basal membrane (white arrow) is intact, and the dermis is not
invaded. Irregular acanthosis (long black arrow) is obvious.
Notice that hair follicles are affected (short arrow). H&E stain;
bar = 200 µm. F—Photomicrograph of a section of the BISC
from panel D at high magnification. Notice acanthosis, hyper-
pigmentation (brown cells), clumped keratohyalin granules
(white arrow), loss of polarity, and anisokaryosis (branched
arrow). H&E stain; bar = 50 µm.
Figure 2—Establishment of broad-range and narrow-range PCR
assays for detection of carnivore PVs. Polymerase chain reaction
products were loaded on agarose gels and stained with ethidi-
um bromide. A—Amplification of cloned DNA by either broad-
range (450 bp) or narrow-range PCR assay (341 bp). Lane 1 =
Water in place of DNA added to the reaction. Lane 2 = DNA
from a commercially available phagemid.h Lane 3 = DNA from
oral CaPV cloned into the phagemid.h Lane 4 = DNA from CPV3
(GenBank accession No. DQ295066) cloned into the phagemid.h
M1 = Molecular weight marker (100-bp ladder). B—The DNA
was extracted from tissues before being amplified by either the
narrow range or the broad-range PCR assays. M2 = 1-kilobase
ladder. M1 = 100-bp ladder. Lane 1 = Negative control with no
DNA added to the reaction. Lane 2 = Extract from canine wart
tissue, which had typical PV-induced inclusion bodies on histo-
logic examination. Lane 3 = Extract from a tumor specimen of a
cat with SCC (GenBank accession No. DQ085784). Lane 4 =
Extract from SSC sample No. 39.
4c
Sequence analysis—The nucleotide sequence of
the amplified DNA was determined and the resulting
sequences were compared to assess whether novel PV-
like sequences had been detected. Indeed, use of the
basic local alignment search toole revealed relatedness to
PV E1 sequences for all 9 samples that were positive for
PV DNA. Relation to HuPV, FePV, CaPV, rat PV, and
BoPV was evident. Clustal alignmentsg revealed the var-
ious degrees of relationship of the newly determined
sequences among each other as well as in comparison
with known PVs. Overall, CaPVs and FePVs were most
closely related to the newly detected viral sequences,
with a relative amino acid identity of 56% to 71%.
Among the HuPVs, types 4, 55, 63, 65, 71, and 74 were
aligned most frequently but type 71 most often had the
closest relationship to the new sequences with 58% to
61% amino acid identity. Among the BoPVs, type 5 was
the closest relative, having 55% to 62% amino acid iden-
tity. A phylogenic tree drawn from the aligned sequences
divided the new sequences into 4 clusters (Figure 3). In
cluster 1, BISC sample No. 15 was situated most closely
with CaPV and FePV. Cluster 2 was occupied by BISC
sample No. 10 and was between FePV and HuPV type
71. Cluster 3 was represented by BISC sample No. 2 and
found close to HuPV type 71. The remaining sequences
(SCC sample Nos. 15, 24, 28, and 29 and BISC sample
Nos. 5 and 6) represented a fourth cluster, which was
clearly distinct from BoPV type 5 on the most distant
side and HuPV type 71, FePV, and CaPV on the less dis-
tant side. These results suggested the presence of thus
far unidentified PVs in tissues representing invasive SCC
and BISC. Interestingly, sequences obtained from speci-
mens of 3 cats with invasive SCC (SCC sample Nos. 15,
24, and 28) had identical sequences. Furthermore, it
was observed that not a single sample from invasive SCC
specimens had been associated with the more classic
FePV and CaPV. However, because the classification of
PVs is based on the sequence of L1, the exact taxonom-
ic position of these novel PV-like sequences could not be
assigned.
Discussion
The purpose of our study was to detect and par-
tially characterize PV DNA in samples representing in
situ and invasive types of SCC in cats to learn more
about PV variants in cats and about possible associa-
tions of these viruses with individual forms of SCC in
cats. Two types of PCR-assays, a narrow range and a
broad-range PCR, were applied to extend the range of
targeted PVs as far as possible.
Careful macroscopic selection and microscopic
confirmation resulted in the identification of 22 sam-
ples representing invasive SCC and 21 samples repre-
senting BISC, which were available for virologic analy-
sis by PCR assay. Papillomavirus DNA was detected in
4 of 22 samples representing invasive SCC and in 5 of
21 samples representing BISC, whereas all nontumor
control samples had negative results for PV DNA. Only
1 (BISC sample No. 15) of the 9 viral DNAs had been
revealed by the narrow-range PCR assay. However, the
same narrow-range PCR assay amplified PV DNA
extracted from canine warts, which was expected
because the primers had been chosen for their homol-
ogy with conserved sequences within E1 of FePV and
CaPV. Yet, the restricted range of these primers was
confirmed, as they proved unable to amplify DNA from
the more distantly related bovine fibropapilloma virus.
These results indicate that the remaining samples with
positive results for PV DNA did not harbor conven-
tional FePV or CaPV.
Eight samples, which had negative results for PV
DNA on narrow-range PCR assay, had positive results
for PV DNA on broad-range PCR assay. The broad-
range PCR assay made use of a second set of primers
that were also derived from E1 but known to uncover
a large variety of HuPVs.30 In our study, this second set
of primers also amplified DNA from bovine fibropapil-
loma virus as well as viral DNA from canine warts.
Sequencing of the amplification products obtained
from the 8 samples revealed novel PV-related DNAs,
although relations to HuPV, FePV, CaPV, rat PV, and
BoPV were evident. A phylogenic tree drawn from the
aligned sequences divided the new sequences into 4
clusters. Three of those clusters had close relationship
to CaPV, FePV, and HuPV. Interestingly, the fourth clus-
ter, represented by 6 amplification products, was clear-
ly distinct from BoPV type 5 and from HuPV type 71,
FePV, and CaPV. Judging from the limited sequence
information available, it appeared as if this fourth clus-
ter represented a novel group of FePVs that had not
been detected previously and that may be associated
with SCC in cats. Notably, all PVs detected in associa-
tion with invasive SCC were found to belong to this
novel cluster.
This represents, to our knowledge, the first evi-
dence of thus far unknown PV-like sequences associat-
ed with SCC in cats. Interestingly, some of the novel
sequences were found in association with invasive
SCC. Notably, previous attempts to detect convention-
al PV antigens in such lesions had failed,23 which led to
the hypothesis that invasive carcinomas of cats are
probably not virally induced, whereas instances of
Bowen’s disease in cats are probably PV-induced.7 Our
findings clearly challenge the former opinion, although
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Figure 3—Phylogenetic relationships of the newly detected PV
sequences with known PV E1 sequences (ie, CaPV, FePV, HuPV,
and BoPV are represented by GenBank accession Nos. D55633,
AF377865, AY330623, and AJ620206, respectively). IS = BISC.
SCC= Invasive SCC. Units indicate the number of substitution
events (percentage of nucleotides),
a causative correlation between the disease and the
novel PV strains has not yet been shown. Results of
another study24 did reveal PV antigens in 44% of BISCs.
Although the proportion of BISC samples with positive
results for PV DNA in our study is lower (5 of 21 BISC
samples), it should be kept in mind that the broad-
range PCR assay may not be able to reveal all variants
of FePVs. Furthermore, it is well-known that PCR
detection of viral nucleic acids in formalin-fixed and
paraffin-embedded tissues may be decreased in com-
parison to fresh tissue.29 Finally, the absence of PV
DNA in SCC samples can also be explained by the so-
called hit-and-run model, which postulates an initial
transformation of the infected cell and a subsequent
loss of PV DNA.31
Full proof of the existence of the novel PVs that
are predicted through the results of our study still
needs to be provided. However, we suggest that a
great diversity of FePVs may exist that is in need of
detection and characterization. The future use of
the technique applied here will help in identifying
more affected cats with papilloma-associated dis-
eases. Virologic studies can be initiated with the
aim to better characterize these novel viruses.
Cloning and sequencing of the entire genomes of
these viruses will allow phylogenetic comparisons
with HuPVs as well as discrimination between
benign and high-risk variants. Such studies can
eventually provide insights into the molecular path-
ways underlying the pathogenesis of these viruses
in cats.
a. QIAshredderTM column b, Qiagen, Basel, Switzerland.
b. QIAamp DNA Mini Kit, Qiagen, Basel, Switzerland.
c. Pfu Turbo DNA polymerase, Stratagene, La Jolla, Calif.
d. QIAquick gel extraction kit, Qiagen, Basel, Switzerland.
e. AB-3100-based fluorescent sequencing and BigDye terminator
chemistry, Synergene Biotech GmbH, Biotech Center Zurich,
Schlieren, Switzerland.
f. NCBI BLAST, National Center for Biotechnology Information,
Bethesda, Md. Available at: www.ncbi.nlm.nih.gov/BLAST/.
Accessed Oct 10, 2005.
g. Lasergene Biocomputing Software for the Macintosh, version
x.x, DNAStar Inc, Madison, Wis.
h. pBluescript, Stratagene, La Jolla, Calif.
References
1. Grossmann D, Leffell DJ. Squamous cell carcinoma. In:
Freedberg IM, Eisen AZ, Wolff K, et al, eds. Fitzpatrick’s dermatology
in general medicine. Vol 1. 6th ed. New York: McGraw-Hill Book Co,
2003;xxx–xxx.
2. Kane CL, Kheen CA, Smithberger E, et al. Histopathology of
cutaneous squamous cell carcinoma and its variants. Semin Cutan
Med Surg 2004;23:54–61.
3. Anwar J, Wrone DA, Kimyai-Asadi A, et al. The develop-
ment of actinic keratosis into invasive squamous cell carcinoma: evi-
dence and evolving classification schemes. Clin Dermatol
2004;22:189–196.
4. Arlette JP, Trotter MJ. Squamous cell carcinoma in situ of the
skin: history, presentation, biology and treatment. Australas J
Dermatol 2004;45:1–11.
5. Cockerell CJ. Pathology and pathobiology of the actinic
(solar) keratosis. Br J Dermatol 2003;149:34–36.
6. Mitsuishi T, Kawana S, Kato T, et al. Human papillomavirus
infection in actinic keratosis and bowen’s disease: comparative
study with expression of cell-cycle regulatory proteins
p21(Waf1/Cip1), p53, PCNA, Ki-67, and Bcl-2 in positive and neg-
ative lesions. Hum Pathol 2003;34:886–892.
7. Scott DW, Miller WH, Griffin CE. Neoplastic and non-neo-
plastic tumors. In: Scott DW, Miller WH, Griffin CE, eds. Muller and
Kirk’s small animal dermatology. 6th ed. Philadelphia: WB Saunders
Co, 2001;1236–1413.
8. Paul CF, Ho VC, McGeown CE, et al. Risk of malignancies
in psoriasis patients treated with cyclosporine: a 5 y cohort study. 
J Invest Dermatol 2003;120:211–216.
9. zur Hausen H. Papillomavirus infections—a major cause of
human cancers. Biochim Biophys Acta 1996;1288:F55–F78.
10. zur Hausen H. Papillomaviruses and cancer: from basic
studies to clinical application. Nat Rev Cancer 2002;2:342–350.
11. Antonsson A, Erfurt C, Hazard K, et al. Prevalence and type
spectrum of human papillomaviruses in healthy skin samples col-
lected in three continents. J Gen Virol 2003;84:1881–1886.
12. Antonsson A, Hansson BG. Healthy skin of many animal
species harbors papillomaviruses which are closely related to their
human counterparts. J Virol 2002;76:12537–12542.
13. de Villiers EM, Fauquet C, Broker TR, et al. Classification of
papillomaviruses. Virology 2004;324:17–27.
14. Lowy DR, Howley PM. Papillomaviruses. In: Knipe DMH,
Howley PM, Griffin DE, et al, eds. Fields’ virology. Vol 2. 4th ed.
Philadelphia: Lippincott Williams & Wilkins, 2001;2231–2264.
15. Pfister H. Chapter 8: human papillomavirus and skin cancer.
J Natl Cancer Inst Monogr 2003;(31):52–56.
16. Saveria-Campo M. Animal models of papillomavirus patho-
genesis. Virus Res 2002;89:249–261.
17. Smith KT, Campo MS. Papillomaviruses and their involve-
ment in oncogenesis. Biomed Pharmacother 1985;39:405–414.
18. Tachezy R, Duson G, Rector A, et al. Cloning and genomic
characterization of Felis domesticus papillomavirus type 1. Virology
2002;301:313–321.
19. Carpenter JL, Kreider JW, Alroy J, et al. Cutaneous xan-
thogranuloma on an eyelid of a cat. Vet Dermatol 1992;3:187–190.
20. Egberink HF, Berrocal A, Bax HA, et al. Papillomavirus asso-
ciated skin lesions in a cat seropositive for feline immunodeficiency
virus. Vet Microbiol 1992;31:117–125.
21. Lozano-Alarcon F, Lewis TP II, Clark EG, et al. Persistent
papillomavirus infection in a cat. J Am Anim Hosp Assoc
1996;32:392–396.
22. Sundberg JP, VanRanst M, Montali R, et al. Feline papillomas
and papillomaviruses. Vet Pathol 2000;37:1–10.
23. Sundberg JP, Junge RE, Lancester WD.
Immunoperoxidase localization of papillomaviruses in hyperplas-
tic and neoplastic epithelial lesions in animals. Am J Vet Res
1984;45:1441–1446.
24. LeClerc SM, Clark EG, Haines DM. Papillomavirus infection
in association with feline cutaneous squamous cell carcinoma in situ,
in Proceedings. Am Assoc Vet Derm Am Coll Vet Derm
1997;13:125–126.
25. Schulman FY, Krafft AE, Janczewski T. Feline cutaneous
fibropapillomas: clinicopathologic findings and association with
papillomavirus infection. Vet Pathol 2001;38:291–296.
26. Gross TL, Ihrke PJ, Walder EJ, et al. Epidermal tumors. In:
Gross TL, Ihrke PJ, Walder EJ, et al, eds. Skin diseases of the dog and
cat: clinical and histopathological diagnosis. Oxford, England:
Blackwell Publishing Ltd, 2005;562–577.
27. Baer KE, Helton K. Multicentric squamous cell carcinomas
in situ resembling Bowen’s disease in cats. Vet Pathol
1993;30:535–543.
28. Miller WH, Affolter VK, Scott DW, et al. In situ resembling
Bowen’s disease in five cats. Vet Dermatol 1992;3:177–182.
29. Albini S, Zimmermann W, Neff F, et al. Identification and
quantification of ovine gammaherpesvirus 2 DNA in fresh and stored
tissues of pigs with symptoms of porcine malignant catarrhal fever. 
J Clin Microbiol 2003;41:900–904.
30. Iftner A, Klug SJ, Garbe C, et al. The prevalence of human
papillomavirus genotypes in nonmelanoma skin cancers of nonim-
munosuppressed individuals identifies high-risk genital types as pos-
sible risk factors. Cancer Res 2003;63:7515–7519.
31. Smith KT, Campo MS. “Hit and run” transformation of
mouse C127 cells by bovine papillomavirus type 4: the viral DNA is
required for the initiation but not for maintenance of the trans-
formed phenotype. Virology 1988;164:39–47.
2040 AJVR, Vol 67, No. 12, December 2006
AJVR, Vol 67, No. 12, December 2006 2041
Appendix
New papillomaviruslike sequences.
GenBank Sample type
accession No. and No. Sequences
DQ085782 BISC 15 1 ATGGTACAAT GGGCATTTGA CAATAAGTAC ACAGATGAAG CAGAGATAGC TTTTCATTAT
61 GCACGTTTGG CAGAGGAGGA TGCAAATGCA GAGGCTTGGT TAAAAAGCAA CTCCCAAGCT
121 AAATATGTCC GAGATTGTGC GCAAATGGTG AAGCTGTATC TTAGACAAGA AATGAGGCAG
181 ACTACTATTT CTGAATGGAT TGACAAGTGC TGCCAGTCAG TGACAGAGGA CGGTGACTGG
241 GGGGATATTA TGCGCTTCTT AAAATATCAG CAAGTTAATT TCACTCAGTT TTTAACTGCC
301 ATGAGAAATG CTTTAGAGGG TAAACCTAAA AAAAACTGCT TAGTATTTTA TGGGCCTCCA
361 GATACTGGCA AGTCATATTT CTGCTTTAGT TTGGTTAGTT TTATGCAGGG GAAAGTGGTG
421 AATTTTATGA ATAGCAA
DQ085783 BISC 2 1 ANGAGGAACG ATATAGCCTA CCACTATGCA TTGCTAGCCG ACGAGGACAC AAATGCAGCG
61 GCATGGCTAG GTACAAACTC ACAGGCCAAG CATGTCAGGG ACTGCGCAGT GATGGTCAAG
121 CATTACAGGC GTGCCATAAT GTCTGCCATG AGTATGTCCG AATGGATAAA CAGACGAATG
181 GGCCTGATAG AGGAGGAAGG AGACTGGAAA AACATAGGCA ATTTCCTCAG ATACCAGGGT
241 ATAGAGGTTA TTACATTTAT AGGGGCGCTG AGGGACATGT TAAAGGGCAT TCCAAAAAGG
301 ACATGTATGT GTATAGTGGG ACCACCAGAC ACAGGGAAAT CAGCGTTTTG CCTTAGCCTG
361 CTAGACTTCT TCGGGGGTAG GGTACTGTCA TTCACCAATT ACAAAAGCCA TTTTTGNTGN
421 CCNACCCTCA A
DQ085784 SCC 15, 24, and 28 1 TTATGGTACA NGTGGGCATT TGACAATAAG TACACAGATG AAGCAGAGAT AGCTTTTCAT
61 TATGCACGTT TGGCAGAGGA GGATGCAAAT GCAGAGGCTT GGTTAAAAAG CAACTCCCAA
121 GCTAAATATG TCCGAGATTG TGCGCAAATG GTGAAGCTGT ATCTTAGACA AGAAATGAGG
181 CAGACTACTA TTTCTGAATG GATTGACAAG TGCTGCCAGT CAGTGACAGA GGACGGTGAC
241 TGGGGGGATA TCATGCGCTT CTTAAAATAT CAGCAAGTTA ATTTCACTCA GTTTTTAACT
301 GCCATGAGAA ATGCTTTAGA GGGTAAACCT AAAAAAAACT GCTTAGTATT TTATGGGCCT
361 CCAGATACTG GCAAGTCATA TTTCTGCTTT AGTTTGGTTA GTTTATGCAT GGAAAGTGGA
421 TTTNA
DQ085785 SCC 29 1 TTATGCACGT TTGGCAGAGG AGGATGCAAA TGCAGAGGCT TGGTTAAAAA GCAACTCCCA
61 AGCTAAATAT GTCCGAGATT GTGCGCAAAT GGTGAAGCTG TATCTTAGAC AAGAAATGAG
121 GCAGACTACT ATTTCTGAAT GGATTGACAA GTGCTGCCAG TCAGTGACAG AGGACGGTGA
181 CTGGGGGGAT ATTATGCGCT TCTTAAAATA TCAGCAAGTT AATTTCACTC AGTTTTTAAC
241 TGCCATGAGA AATGCTTTAG AGGGTAAACC TAAAAAAAAC TGCTTAGTAT TTTATGGGCC
301 TCCAGATACT GGCAAGTCAT ATTTCTGCTT TAGTTTGGTT AGTTTATGCT TGAAAGTGGA
DQ085786 BISC 6 1 TTTTATGGTA CAGTGGGCAT TTGACAATGA ATACTTTGAG GAAAGTGAGA TAGCATATCA
61 GTATGCATGC CTTGCAGAAA CAGAAGAAAA TGCTGCAGCC TTCCTAAATT CTAACAGCCA
121 AGCTAAGCAT GTCAGGGACT GTGCAACTAT GTGCAGATAT TATAAGAGAG CAGAAATGCA
181 GAGAATGTCA ATGTCCGCCT GGATTCACAA GAGATGTAAG GAGACCAGCC TGCAGGGAGA
241 TTGGAAAGAA ATAGTCAAGT TTCTTAGACA TCAAAGTGTA GAGTTTATTA CCTTTCTCTG
301 CAGCTTCAAG AAATTTCTCA GGGGTGTGCC TAAAAAAAAT TGCATGCTTT TCTGGGGTCC
361 TCCTAACACA GGCAAATCTA TGTTTTGCAT GAGCTTACTT TCTTTCCTAA AGGCANAGAT
421 TCTTTANC
DQ085788 BISC 5 1 TTCTTATGGT ACAGTGGGCA TTTGACAATA AGTACACAGA TGAAGCAGAG ATAGCTTTTC
61 ATTATGCACG TTTGGCAGAG GAGGATGCAA ATGCAGAGGC TTGGTTAAAA AGCAACTCCC
121 AAGCTAAATA TGTCCGAGAT TGTGCGCAAA TGGTGAAGCT GTATCTTAGA CAAGAAATGA
181 GGCAGACTAC TATTTCTGAA TGGATTGACA AGTGCTGCCA GTCAGTGACA GAGGACGGTG
241 ACTGGGGGGA TATTATGCGC TTCTTAAAAT ATCAGCAAGT TAATTTCACT CAGTTTTTAA
301 CTGCCATGAG AAATGCTTTA GAGGGTAAAC CTAAAAAAAA CTGCTTAGTA TTTTATGGGC
361 CTCCAGATAC TGGCAAGTCA TATTTCTGCT TTAGTTTGGT TAGTTTATGC AGGGAAAGTG
421 TATTTAAAA
DQ085789 BISC 10 1 TTTTTNTGGT NNCCAGTGGC NTACGATAAC GACTTCCGTG ACGAGTGCCA AATTGCCTAC
61 GAATATGCAC GGCTTGCCAC GGAGGACAGC AATGCATTGG CATGGTTGGA ATGCAATAAT
121 CAGGCCAAAT TTGTCAAAGA CTGTGCACGT ATGGTCGGGT ACTATAAGCG CGCTGAAATG
181 CAAAATATGT CTATCTCTGC TTGGATACNT AAGCAAATTA AAGATAGGCA GTGCACTACC
241 GATTGGAAAG TAATTNTGAA TTTTCNTAAG TTTCANCATG TGGAGGTTAT AATTTTTTTA
301 AATGCAATGA TGCATTTGCT CCGTGGCACG CCAAAGAAAA ATTGTCTGGT TCTGTACGGT
361 CCCCCAAATA CAGGGAAATC CATGTTCGCA ATGAGCTTAA TTCAGTGTCT GAAAGGACGT
421 GTATTGTNGT ATGTGAATTC ACGTAGTCAG TTNTGGTTGC ANCCCTTGGC AGATGCAAAA
481 ATAGCACTGC TGGACGATGC AACCAGACCA TGCTGGGAAC TATATAGATA TTTATTGAGA
541 AATGCATTGG ATGGTAATCC TATATGCCTG ACTAANCNAG C
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